DynPort Vaccine Company LLC, a CSC company, is a technology integrator providing solutions that protect humanity from emerging threats. DVC has comprehensive experience in the advanced development of biodefense biologics, including live attenuated vaccines, recombinant vaccines, therapeutics, therapeutic polyclonal antibodies and alternative vaccine delivery systems. The DVC pipeline includes botulinum polyclonal antibodies, butyrylcholinesterase ("BioScavenger"), and vaccines for plague, tularemia, botulinum neurotoxin and seasonal and pandemic influenza. For more information and current career opportunities, visit www.csc.com/dvc.

©Copyright Phacilitate Limited 2009

Click here to download the last three North American Vaccine Forum Main Announcements

Over 50 sponsors and exhibitors participated in 2009, with the floorplan sold out!

Click here to find out how your company can participate.